These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21984063)

  • 1. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.
    Pang B; Fan H; Zhang IY; Liu B; Feng B; Meng L; Zhang R; Sadeghi S; Guo H; Pang Q
    J Neurooncol; 2012 Feb; 106(3):543-9. PubMed ID: 21984063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas.
    Ning S; Liang N; Liu B; Chen X; Pang Q; Xin T
    Neurol Sci; 2013 Oct; 34(10):1745-50. PubMed ID: 23397225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
    Jensen RL; Ragel BT; Whang K; Gillespie D
    J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of Hedgehog/Gli1 pathway on angiogenesis in gliomas.
    Cui D; Chen X; Yin J; Wang W; Lou M; Gu S
    Neurol India; 2012; 60(6):589-96. PubMed ID: 23287320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
    Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
    Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma.
    Ma C; Li Y; Zhang X; Zhao G; Xu H
    J Int Med Res; 2014 Feb; 42(1):198-204. PubMed ID: 24398760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of vasculogenic mimicry in human gliomas.
    Liu XM; Zhang QP; Mu YG; Zhang XH; Sai K; Pang JC; Ng HK; Chen ZP
    J Neurooncol; 2011 Nov; 105(2):173-9. PubMed ID: 21533525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
    Komatsu K; Nakanishi Y; Nemoto N; Hori T; Sawada T; Kobayashi M
    Brain Tumor Pathol; 2004; 21(3):105-12. PubMed ID: 15696970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.
    Wang M; Wang T; Liu S; Yoshida D; Teramoto A
    Brain Tumor Pathol; 2003; 20(2):65-72. PubMed ID: 14756443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma.
    Xue S; Hu M; Li P; Ma J; Xie L; Teng F; Zhu Y; Fan B; Mu D; Yu J
    Oncotarget; 2017 Jul; 8(30):49702-49712. PubMed ID: 28591697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group A1 expression correlates with the histological grade of human glial tumors.
    Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A
    Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma.
    Chen X; Ma WY; Xu SC; Liang Y; Fu YB; Pang B; Xin T; Fan HT; Zhang R; Luo JG; Kang WQ; Wang M; Pang Q
    J Neurooncol; 2014 Aug; 119(1):39-47. PubMed ID: 24906438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
    Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1.
    Li KK; Qi Y; Xia T; Yao Y; Zhou L; Lau KM; Ng HK
    PLoS One; 2015; 10(5):e0127910. PubMed ID: 26009886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
    Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
    Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.